carbapenems has been researched along with Dysmyelopoietic Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruns, AHW; de Groot, MCH; Niessen, FA; Raijmakers, RAP; van der Bruggen, T; van Mourik, MSM | 1 |
| Azuma, R; Harada, H; Mori, H; Niikura, H; Omine, M; Sakai, H; Sanada, M; Shimamoto, K | 1 |
2 other study(ies) available for carbapenems and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Carbapenems; Controlled Before-After Studies; Female; Humans; Interrupted Time Series Analysis; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Practice Guidelines as Topic; Retrospective Studies; Stem Cell Transplantation; Vancomycin | 2020 |
[Clinical evaluation of biapenem for febrile neutropenia in patients with hematological disorders].
Topics: Anemia, Aplastic; Carbapenems; Fever; Hematologic Diseases; Humans; Infusions, Intravenous; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Myelodysplastic Syndromes; Neutropenia; Thienamycins; Treatment Outcome | 2007 |